Gerresheimer sells Centor and Primary Packaging Plastics units to Apax Partners for €1.5 billion
Gerresheimer announced it is divesting two of its businesses, the Centor unit and the Primary Packaging Plastics (PPP) unit, to private‑equity firm Apax Partners. The transaction is valued at roughly €1.5 billion.
The sale is part of Gerresheimer’s strategy to focus on its core glass packaging and drug‑delivery operations, allowing the company to streamline its portfolio and invest in higher‑growth areas.
The announcement coincided with reports that other companies such as Resilience and Eli Lilly are expanding capacity for injectable pens, highlighting ongoing investment in the injectable market.
Details on the timing of the closing and any impact on employees were not disclosed in the brief report.
This writeup was produced by pharmadog from original reporting by Endpoints.
Original headline: “Gerresheimer divests two businesses worth €1.5B; Resilience, Lilly boost injectable pen capacity”
read at Endpoints ↗
comments(0)
5-min edit window · permanent after that